Accelerating BioVenture Innovation
Learn about the full suite of exciting entrepreneurial initiatives & resources offered by Weill Cornell Medicine at our Fall Kickoff, including our annual 12-week course & training program in biomedical entrepreneurship, Accelerating BioVenture Innovation.
ABI builds teams around patented technologies originating from Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center & Rockefeller University. The ABI entrepreneurship course & training program is organized & sponsored by Weill Cornell Medicine's BioVenture eLab & the Office of BioPharma Alliances & Research Collaborations. Participants include Principal Investigators, postdocs, graduate & medical students & serial entrepreneurs.
This event will also feature an exciting Keynote speaker-see below- & an ABI Success Story. Learn first-hand from a scientist-entrepreneur how ABI helped turn early-stage research into a successful new venture.
5:30pm - Registration & Networking
6:00pm - Opening Remarks
Larry Schlossman, Managing Director, BioPharma Alliances & Research Collaborations
Weill Cornell Medicine
Jahan Ali, PhD, Director, BioVenture eLab, Weill Cornell Medicine
6:15pm - Keynote Speaker
David Fischell, PhD, Chief Executive Officer, Angel Medical Systems; Chairman of the Cornell University Biomedical Engineering Advisory Board; Fellow of the American Institute for Medical & Biological Engineering; Weill Cornell Medicine Board of Overseers
6:45pm - Accelerating BioVenture Innovation Success Story
Dan Heller, PhD, Head, Cancer Nanomedicine Laboratory; Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chair; Associate Member, Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center; Associate Professor, Weill Cornell Medicine, Cornell University